Streetbeat News

Stock Prices

AAPL

MSFT

NVDA

Generative AI startups are capturing 40% of venture capital investments in the cloud sector, as major tech companies like Apple, Microsoft, and Nvidia race towards a $4 trillion valuation. The cloud industry sees a 27% annual increase in funding, driven by AI advancements.

Portfolio Pulse from Pooja Rajkumari

October 16, 2024 | 1:46 pm

ASML

ASML has announced that it expects the slowdown in the chip market to persist well into 2025, as stated during a conference call.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 1:34 pm

AIFF

Firefly Neuroscience shares have been halted after experiencing a significant increase of 60.70%.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 1:33 pm

DRUG

Bright Minds Biosciences shares were halted after experiencing a significant drop of 27.41%.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 1:33 pm

MS

NVDA

USB

Morgan Stanley and US Bank shares rose due to strong earnings reports. Bitcoin surpassed $67,000, and NVIDIA's stock recovered after a selloff on Tuesday.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 1:32 pm

CGEM

Cullinan Therapeutics shares rose after the FDA approved their IND application for CLN-978.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 1:29 pm

INDS

PLD

SPRE

Prologis, Inc. (NYSE:PLD) reported Q3 earnings with FFO beating expectations but revenue missing. The company revised its FY24 guidance slightly upwards. Prologis' shares rose 1.32% premarket. Investors can also gain exposure through ETFs like Pacer Industrial Real Estate ETF (NYSE:INDS) and SP Funds S&P Global REIT Sharia ETF (NYSE:SPRE).

Portfolio Pulse from Lekha Gupta

October 16, 2024 | 1:18 pm

BITF

CAN

CLSK

COIN

HIVE

HUT

MARA

MSTR

RIOT

Shares of miners and crypto-linked stocks are trading higher following Bitcoin's rise above $67,000.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 1:17 pm

NVAX

The FDA has placed a clinical hold on Novavax's COVID-19-influenza combination vaccine trial due to a serious adverse event reported in a participant. This has led to a significant drop in Novavax's stock price.

Portfolio Pulse from Vandana Singh

October 16, 2024 | 1:16 pm

ASML

ASML's CEO expressed optimism about the company's long-term prospects during a conference call, indicating positive developments ahead.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 1:15 pm